Mitogen-activated protein kinase mediation of hemolysate-induced contraction in rabbit basilar artery
- 1 June 1999
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 90 (6) , 1091-1097
- https://doi.org/10.3171/jns.1999.90.6.1091
Abstract
Object. Mitogen-activated protein kinase (MAPK) is an important signaling factor in vascular proliferation and contraction, which are the two features of cerebral vasospasm that follow subarachnoid hemorrhage. The authors studied the possible involvement of MAPK in hemolysate-induced signal transduction and contraction in rabbit basilar artery (BA).Methods. Isometric tension was used to record the contractile response of rabbit BA to hemolysate, and Western blots were obtained using antibodies for MAPK.The following results are reported. 1) Hemolysate produced a concentration-dependent contraction of rabbit BA; however, preincubation of arteries with the MAPK kinase (MEK) inhibitor PD-98059 markedly reduced this contraction. The administration of PD-98059 also relaxed, in a concentration-dependent fashion, the sustained contraction induced by 10% hemolysate. 2) The Janus tyrosine kinase 2 inhibitor AG-490, preincubated with arterial rings, reduced the contractile response to hemolysate but failed to relax the sustained contraction induced by this agent. The Src-tyrosine kinase inhibitor damnacanthal and the phosphatidylinositol 3—kinase inhibitor wortmannin failed to reduce hemolysate-induced contraction. 3) Hemolysate produced a time-dependent elevation of MAPK immunoreactivity as seen on Western blots of rabbit BA. The MAPK was enhanced 1 minute after hemolysate exposure and the effect reached maximum levels at 5 minutes. The immunoreactivity of MAPK decayed slowly over time, but the level of this kinase was still higher than the basal level, even at 2 hours after exposure to hemolysate. Preincubation of arteries with the MEK inhibitor PD-98059 abolished the effect of hemolysate on MAPK immunoreactivity.Conclusions. Hemolysate produced contraction of rabbit BA, possibly by activation of MAPK, and therefore MAPK inhibitors may be useful in the treatment of cerebral vasospasm.Keywords
This publication has 45 references indexed in Scilit:
- Endothelin B Receptor Antagonists Attenuate Subarachnoid Hemorrhage–Induced Cerebral VasospasmStroke, 1998
- Role of tyrosine kinase in erythrocyte lysate—induced contraction in rabbit cerebral arteriesJournal of Neurosurgery, 1998
- Angiotensin II Signaling in Vascular Smooth MuscleHypertension, 1997
- Activity of Smooth Muscle Phosphatases 1 and 2A in Rabbit Basilar Artery in VasospasmStroke, 1995
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Identification of mitogen‐activated protein kinase phosphorylation sequences in mammalian h‐CaldesmonFEBS Letters, 1993
- Treatment of cerebral vasospasm with intra-arterial papaverineJournal of Neurosurgery, 1992
- Tyrosyl Phosphorylation and Activation of MAP Kinases by p56
lck
Science, 1992
- Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasmJournal of Neurosurgery, 1992
- Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model.Stroke, 1985